OnKure Therapeutics, Inc. (OKUR)

3.63 -0.16 (-4.22%) USD  |  NASDAQ  |  Aug 31, 16:00
3.69 +0.06 (+1.65%) Pre-Market: 20:00
More

OnKure Therapeutics Revenue Estimates for Next Fiscal Year

Revenue Estimates for Next Fiscal Year Chart

View Revenue Estimates for Next Fiscal Year for OKUR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue Estimates for Next Fiscal Year Chart
Start Trial

Historical Revenue Estimates for Next Fiscal Year Data

View and export this data back to 2024. Start Trial.
Date Value
August 14, 2026 --
August 05, 2026 --
July 16, 2026 --
July 15, 2026 --
June 23, 2026 --
May 06, 2026 --
March 30, 2026 --
March 28, 2026 --
March 16, 2026 --
March 13, 2026 --
March 12, 2026 --
February 10, 2026 --
November 10, 2025 --
November 07, 2025 --
October 27, 2025 --
October 23, 2025 --
October 16, 2025 --
Date Value
August 26, 2025 --
August 15, 2025 --
August 13, 2025 --
August 12, 2025 --
July 27, 2025 --
June 03, 2025 --
May 09, 2025 --
May 07, 2025 --
April 15, 2025 --
March 14, 2025 --
March 12, 2025 --
March 10, 2025 --
January 28, 2025 --
December 05, 2024 --
November 08, 2024 --
October 17, 2024 --
October 10, 2024 --

Revenue Estimates for Next Fiscal Year Range, Past 5 Years

View Revenue Estimates for Next Fiscal Year Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Next Fiscal Year Benchmarks

View Revenue Estimates for Next Fiscal Year Benchmarks
Start Trial
Ironwood Pharmaceuticals, Inc. Upgrade
Theriva Biologics, Inc. Upgrade
Nkarta, Inc. Upgrade
Unicycive Therapeutics, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade

Revenue Estimates for Next Fiscal Year Related Metrics

Revenue Estimates for Current Quarter Upgrade
Revenue Estimates for Next Quarter Upgrade
Revenue Estimates for Current Fiscal Year Upgrade
EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade